STOCK TITAN

Texas Capital Bancshares (TCBIO) Stock Price, News & Analysis

TCBIO NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
0 252 sessions, October 7, 2025 to October 7, 2026
Largest daily move
-2.9% close of October 8, 2025
1-year change
-15.3% closing prices, October 7, 2025 to October 7, 2026
1-month change
-8.1% closing prices, September 4, 2026 to October 7, 2026

Company Description

Texas Capital Bancshares (NASDAQ: TCBIO) is classified in the state commercial banks industry.

TCBIO has declined 15.3% over the past year. The last closing price was $18.28.

For FY2025, Texas Capital Bancshares reported revenue of $1.3B with net income of $330.2M and diluted earnings per share of $6.79. The company operates at a net profit margin of 26.3%.

This page collects what Stock Titan holds for TCBIO, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-15.3%
Performance 1 year

Texas Capital Bancshares (TCBIO) closed at $18.28 on October 7, 2026. Over the past 12 months, the price has lost 15.3%.

See what a $1,000 investment in TCBIO would be worth today

Average down calculator for TCBIO

TCBIO Metrics & Rankings

Month to date
-0.7%
View ranking
YTD
-9.0%
View ranking

Price returns through October 7, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for TCBIO.

Financial Highlights

Texas Capital Bancshares generated $1.3B in revenue in FY2025, and net income was $330.2M, reflecting a 26.3% net profit margin. Diluted earnings per share stood at $6.79. The company generated $360.2M in operating cash flow.

$1.3B
Revenue (FY2025)
$330.2M
Net Income (FY2025)
$360.2M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Texas Capital Bancshares (TCBIO) currently stands at 14.5 thousand shares, up 1452.8% from the previous reporting period. Since October 2025, short interest has decreased by 15.6%.

Days to Cover History

Last 12 Months

Days to cover for Texas Capital Bancshares (TCBIO) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 4.3 days.

TCBIO Company Profile & Sector Positioning

Texas Capital Bancshares (TCBIO) and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of Texas Capital Bancshares (TCBIO)?

The current stock price of Texas Capital Bancshares (TCBIO) is $18.28 as of October 7, 2026.

What is the revenue of Texas Capital Bancshares (TCBIO) stock?

The FY2025 revenue of Texas Capital Bancshares (TCBIO) is $1.3B, from its most recent completed fiscal year.

What is the net income of Texas Capital Bancshares (TCBIO)?

The FY2025 net income of Texas Capital Bancshares (TCBIO) is $330.2M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of Texas Capital Bancshares (TCBIO)?

The diluted earnings per share (EPS) of Texas Capital Bancshares (TCBIO) is $6.79 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of Texas Capital Bancshares (TCBIO)?

The operating cash flow of Texas Capital Bancshares (TCBIO) is $360.2M for FY2025, its most recent completed fiscal year. Learn about cash flow.

What is the profit margin of Texas Capital Bancshares (TCBIO)?

The net profit margin of Texas Capital Bancshares (TCBIO) is 26.3% for FY2025, its most recent completed fiscal year. Learn about profit margins.